DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 90 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $588,567 | -31.0% | 46,271 | -23.6% | 0.00% | 0.0% |
| Q2 2023 | $852,544 | -15.2% | 60,550 | -7.0% | 0.00% | 0.0% |
| Q1 2023 | $1,005,393 | +15.3% | 65,074 | +22.4% | 0.00% | 0.0% |
| Q4 2022 | $871,669 | -9.4% | 53,183 | +2.3% | 0.00% | -50.0% |
| Q3 2022 | $962,000 | +49.4% | 51,978 | +6.2% | 0.00% | +100.0% |
| Q2 2022 | $644,000 | +35.0% | 48,953 | -4.8% | 0.00% | 0.0% |
| Q1 2022 | $477,000 | -12.2% | 51,413 | -7.5% | 0.00% | 0.0% |
| Q4 2021 | $543,000 | -70.6% | 55,595 | +2.2% | 0.00% | -50.0% |
| Q3 2021 | $1,849,000 | -6.9% | 54,408 | +0.3% | 0.00% | 0.0% |
| Q2 2021 | $1,987,000 | -23.9% | 54,265 | -6.8% | 0.00% | -33.3% |
| Q1 2021 | $2,610,000 | -20.7% | 58,217 | +0.9% | 0.00% | -40.0% |
| Q4 2020 | $3,291,000 | +12.8% | 57,673 | +1.4% | 0.01% | 0.0% |
| Q3 2020 | $2,917,000 | -13.4% | 56,863 | +0.8% | 0.01% | -16.7% |
| Q2 2020 | $3,369,000 | +156.8% | 56,409 | +77.0% | 0.01% | +100.0% |
| Q1 2020 | $1,312,000 | -30.1% | 31,874 | +5.7% | 0.00% | 0.0% |
| Q4 2019 | $1,877,000 | +87.1% | 30,152 | +2.1% | 0.00% | +50.0% |
| Q3 2019 | $1,003,000 | +95.5% | 29,544 | +29.9% | 0.00% | +100.0% |
| Q2 2019 | $513,000 | +60.3% | 22,739 | +65.2% | 0.00% | 0.0% |
| Q1 2019 | $320,000 | +10.7% | 13,767 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $289,000 | -44.2% | 13,767 | +2.9% | 0.00% | 0.0% |
| Q3 2018 | $518,000 | +13.1% | 13,373 | +14.9% | 0.00% | 0.0% |
| Q2 2018 | $458,000 | +78.9% | 11,643 | -8.7% | 0.00% | 0.0% |
| Q1 2018 | $256,000 | -13.2% | 12,750 | -2.0% | 0.00% | 0.0% |
| Q4 2017 | $295,000 | – | 13,007 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 4,104,140 | $93,041,000 | 43.52% |
| SV Health Investors, LLC | 1,716,303 | $38,909,000 | 20.55% |
| PURA VIDA INVESTMENTS, LLC | 68,154 | $1,545,000 | 0.65% |
| Redmile Group, LLC | 683,880 | $14,658,000 | 0.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 77,000 | $1,746,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,154 | $5,008,000 | 0.59% |
| EMERALD ADVISERS, LLC | 482,626 | $10,941,000 | 0.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 416,342 | $9,438,000 | 0.38% |
| Orbimed Advisors | 1,176,070 | $26,662,000 | 0.34% |
| VIKING GLOBAL INVESTORS LP | 2,394,625 | $54,286,000 | 0.33% |